, Volume 49, Issue 11, pp 873–888 | Cite as

Childhood central nervous system leukemia: historical perspectives, current therapy, and acute neurological sequelae

  • Fred H. Laningham
  • Larry E. Kun
  • Wilburn E. Reddick
  • Robert J. Ogg
  • E. Brannon Morris
  • Ching-Hon Pui
Invited Review



During the past three decades, improvements in the treatment of childhood leukemia have resulted in high cure rates, particularly for acute lymphoblastic leukemia (ALL). Unfortunately, successful therapy has come with a price, as significant morbidity can result from neurological affects which harm the brain and spinal cord. The expectation and hope is that chemotherapy, as a primary means of CNS therapy, will result in acceptable disease control with less CNS morbidity than has been observed with combinations of chemotherapy and radiotherapy over the past several decades.

Methods and results

In this review we discuss the poignant, historical aspects of CNS leukemia therapy, outline current methods of systemic and CNS leukemia therapy, and present imaging findings we have encountered in childhood leukemia patients with a variety of acute neurological conditions. A major objective of our research is to understand the neuroimaging correlates of acute and chronic effects of cancer and therapy. Specific features related to CNS leukemia and associated short-term toxicities, both disease- and therapy-related, are emphasized in this review with the specific neuroimaging findings. Specific CNS findings are similarly important when treating acute myelogenous leukemia (AML), and details of leukemic involvement and toxicities are also presented in this entity.


Despite contemporary treatment approaches which favor the use of chemotherapy (including intrathecal therapy) over radiotherapy in the treatment of CNS leukemia, children still occasionally experience morbid neurotoxicity. Standard neuroimaging is sufficient to identify a variety of neurotoxic sequelae in children, and often suggest specific etiologies. Specific neuroimaging findings frequently indicate a need to alter antileukemia therapy. It is important to appreciate that intrathecal and high doses of systemic chemotherapy are not innocuous and are associated with acute, specific, recognizable, and often serious neurological consequences.


Childhood CNS leukemia Neurotoxicity Intrathecal therapy CNS infection Secondary malignancies Methotrexate 


Conflict of interest statement

We declare that we have no conflict of interest.


This work was supported in part by Cancer Center Core Grant CA (21765) and the American Lebanese Syrian Associated Charities (ALSAC).


  1. 1.
    Pui CH, Evans WE (2006) Treatment of acute lymphoblastic leukemia. N Engl J Med 354:166–178PubMedCrossRefGoogle Scholar
  2. 2.
    Creutzig U, Zimmermann M, Ritter J, Reinhardt D, Hermann J, Henze G, Jurgens H, Kabisch H, Reiter A, Riehm H, Gadner H, Schellong G (2005) Treatment strategies and long-term results in paediatric patients treated in four consecutive AML-BFM trials. Leukemia 19:2030–2042PubMedCrossRefGoogle Scholar
  3. 3.
    Gibson BE, Wheatley K, Hann IM, Stevens RF, Webb D, Hills RK, De Graaf SS, Harrison CJ (2005) Treatment strategy and long-term results in paediatric patients treated in consecutive UK AML trials. Leukemia 19:2130–2138PubMedCrossRefGoogle Scholar
  4. 4.
    Pui CH, Cheng C, Leung W, Rai SN, Rivera GK, Sandlund JT, Ribeiro RC, Relling MV, Kun LE, Evans WE, Hudson MM (2003) Extended follow-up of long-term survivors of childhood acute lymphoblastic leukemia. N Engl J Med 349:640–649PubMedCrossRefGoogle Scholar
  5. 5.
    Kun LE (2007) Leukemias in children. Pediatric Radiation Oncology 15–39Google Scholar
  6. 6.
    Mahmoud HH, Rivera GK, Hancock ML, Krance RA, Kun LE, Behm FG, Ribeiro RC, Sandlund JT, Crist WM, Pui CH (1993) Low leukocyte counts with blast cells in cerebrospinal fluid of children with newly diagnosed acute lymphoblastic leukemia. N Engl J Med 329:314–319PubMedCrossRefGoogle Scholar
  7. 7.
    Burger B, Zimmermann M, Mann G, Kuhl J, Loning L, Riehm H, Reiter A, Schrappe M (2003) Diagnostic cerebrospinal fluid examination in children with acute lymphoblastic leukemia: significance of low leukocyte counts with blasts or traumatic lumbar puncture. J Clin Oncol 21:184–188PubMedCrossRefGoogle Scholar
  8. 8.
    Price RA (1979) Histopathology of CNS leukemia and complications of therapy. Am J Pediatr Hematol Oncol 1:21–30PubMedGoogle Scholar
  9. 9.
    Pinkel D (1970) Treatment of childhood acute lymphocytic leukemia. J Pediatr 77:1089–1091PubMedCrossRefGoogle Scholar
  10. 10.
    Creutzig U, Ritter J, Zimmermann M, Hermann J, Gadner H, Sawatzki DB, Niemeyer CM, Schwabe D, Selle B, Boos J, Kuhl J, Feldges A (2001) Idarubicin improves blast cell clearance during induction therapy in children with AML: results of study AML-BFM 93. AML-BFM Study Group. Leukemia 15:348–354PubMedCrossRefGoogle Scholar
  11. 11.
    Krance RA, Hurwitz CA, Head DR, Raimondi SC, Behm FG, Crews KR, Srivastava DK, Mahmoud H, Roberts WM, Tong X, Blakley RL, Ribeiro RC (2001) Experience with 2-chlorodeoxyadenosine in previously untreated children with newly diagnosed acute myeloid leukemia and myelodysplastic diseases. J Clin Oncol 19:2804–2811PubMedGoogle Scholar
  12. 12.
    Woods WG, Neudorf S, Gold S, Sanders J, Buckley JD, Barnard DR, Dusenbery K, DeSwarte J, Arthur DC, Lange BJ, Kobrinsky NL (2001) A comparison of allogeneic bone marrow transplantation, autologous bone marrow transplantation, and aggressive chemotherapy in children with acute myeloid leukemia in remission. Blood 97:56–62PubMedCrossRefGoogle Scholar
  13. 13.
    Stevens RF, Hann IM, Wheatley K, Gray RG (1998) Marked improvements in outcome with chemotherapy alone in paediatric acute myeloid leukemia: results of the United Kingdom Medical Research Council’s 10th AML trial. MRC Childhood Leukaemia Working Party. Br J Haematol 101:130–140PubMedCrossRefGoogle Scholar
  14. 14.
    Ravindranath Y, Yeager AM, Chang MN, Steuber CP, Krischer J, Graham-Pole J, Carroll A, Inoue S, Camitta B, Weinstein HJ (1996) Autologous bone marrow transplantation versus intensive consolidation chemotherapy for acute myeloid leukemia in childhood. Pediatric Oncology Group. N Engl J Med 334:1428–1434PubMedCrossRefGoogle Scholar
  15. 15.
    Boulad F, Kernan NA (1993) Treatment of childhood acute nonlymphoblastic leukemia: a review. Cancer Invest 11:534–553PubMedGoogle Scholar
  16. 16.
    Lowenberg B, Downing JR, Burnett A (1999) Acute myeloid leukemia. N Engl J Med 341:1051–1062PubMedCrossRefGoogle Scholar
  17. 17.
    Raimondi SC, Chang MN, Ravindranath Y, Behm FG, Gresik MV, Steuber CP, Weinstein HJ, Carroll AJ (1999) Chromosomal abnormalities in 478 children with acute myeloid leukemia: clinical characteristics and treatment outcome in a cooperative pediatric oncology group study – POG 8821. Blood 94:3707–3716PubMedGoogle Scholar
  18. 18.
    Bloomfield CD, Shuma C, Regal L, Philip PP, Hossfeld DK, Hagemeijer AM, Garson OM, Peterson BA, Sakurai M, Alimena G, Berger R, Rowley JD, Ruutu T, Mitelman F, Dewald GW, Swansbury J (1997) Long-term survival of patients with acute myeloid leukemia: a third follow-up of the Fourth International Workshop on Chromosomes in Leukemia. Cancer 80:2191–2198PubMedCrossRefGoogle Scholar
  19. 19.
    Sievers EL, Lange BJ, Buckley JD, Smith FO, Wells DA, Igneault-Creech CA, Shults KE, Bernstein ID, Loken MR (1996) Prediction of relapse of pediatric acute myeloid leukemia by use of multidimensional flow cytometry. J Natl Cancer Inst 88:1483–1488PubMedCrossRefGoogle Scholar
  20. 20.
    Pui CH, Dahl GV, Kalwinsky DK, Look AT, Mirro J, Dodge RK, Simone JV (1985) Central nervous system leukemia in children with acute nonlymphoblastic leukemia. Blood 66:1062–1067PubMedGoogle Scholar
  21. 21.
    Graham A, Hodgson T, Jacubowski J, Norfolk D, Smith C (2001) MRI of perineural extramedullary granulocytic sarcoma. Neuroradiology 43:492–495PubMedCrossRefGoogle Scholar
  22. 22.
    Kingsley DP, Kendall BE (1978) Cranial computed tomography in leukaemia. Neuroradiology 16:543–546PubMedCrossRefGoogle Scholar
  23. 23.
    Kitajima M, Korogi Y, Shigematsu Y, Liang L, Matsuoka M, Yamamoto T, Jhono M, Eto K, Takahashi M (2002) Central nervous system lesions in adult T-cell leukemia: MRI and pathology. Neuroradiology 44:559–567PubMedCrossRefGoogle Scholar
  24. 24.
    Majhail NS, Lichtin AE (2004) Acute leukemia with a very high leukocyte count: confronting a medical emergency. Cleve Clin J Med 71:633–637PubMedCrossRefGoogle Scholar
  25. 25.
    Chen CY, Zimmerman RA, Faro S, Bilaniuk LT, Chou TY, Molloy PT (1996) Childhood leukemia: central nervous system abnormalities during and after treatment. AJNR Am J Neuroradiol 17:295–310PubMedGoogle Scholar
  26. 26.
    Eguiguren JM, Schell MJ, Crist WM, Kunkel K, Rivera GK (1992) Complications and outcome in childhood acute lymphoblastic leukemia with hyperleukocytosis. Blood 79:871–875PubMedGoogle Scholar
  27. 27.
    Lowe EJ, Pui CH, Hancock ML, Geiger TL, Khan RB, Sandlund JT (2005) Early complications in children with acute lymphoblastic leukemia presenting with hyperleukocytosis. Pediatr Blood Cancer 45:10–15PubMedCrossRefGoogle Scholar
  28. 28.
    Neglia JP, Robison LL, Stovall M, Liu Y, Packer RJ, Hammond S, Yasui Y, Kasper CE, Mertens AC, Donaldson SS, Meadows AT, Inskip PD (2006) New primary neoplasms of the central nervous system in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Natl Cancer Inst 98:1528–1537PubMedCrossRefGoogle Scholar
  29. 29.
    Paakko E, Talvensaari K, Pyhtinen J, Lanning M (1999) Late cranial magnetic resonance imaging after cranial irradiation in survivors of childhood cancer. Neuroradiology 36:652–655CrossRefGoogle Scholar
  30. 30.
    Rollins N, Winick N, Bash R, Booth T (2004) Acute methotrexate neurotoxicity: findings on diffusion-weighted imaging and correlation with clinical outcome. AJNR Am J Neuroradiol 25:1688–1695PubMedGoogle Scholar
  31. 31.
    Mahoney DH Jr, Shuster JJ, Nitschke R, Lauer SJ, Steuber CP, Winick N, Camitta B (1998) Acute neurotoxicity in children with B-precursor acute lymphoid leukemia: an association with intermediate-dose intravenous methotrexate and intrathecal triple therapy – a Pediatric Oncology Group study. J Clin Oncol 16:1712–1722PubMedGoogle Scholar
  32. 32.
    Pui CH, Evans WE (1999) Acute lymphoblastic leukemia in infants. J Clin Oncol 17:438–440PubMedGoogle Scholar
  33. 33.
    Winick NJ, Bowman WP, Kamen BA, Roach ES, Rollins N, Jacaruso D, Buchanan GR (1992) Unexpected acute neurologic toxicity in the treatment of children with acute lymphoblastic leukemia. J Natl Cancer Inst 84:252–256PubMedCrossRefGoogle Scholar
  34. 34.
    Pedersen H, Clausen N (1981) The development of cerebral CT changes during treatment of acute lymphocytic leukemia in childhood. Neuroradiology 22:79–84PubMedCrossRefGoogle Scholar
  35. 35.
    Morgan GW, Barohn RJ, Bazan C III, King RB, Klucznik RP (1993) Nerve root enhancement with MRI in inflammatory demyelinating polyradiculoneuropathy. Neurology 43:618–620PubMedGoogle Scholar
  36. 36.
    Georgy BA, Chong B, Chamberlain M, Hesselink JR, Cheung G (1994) MR of the spine in Guillain-Barre syndrome. AJNR Am J Neuroradiol 15:300–301PubMedGoogle Scholar
  37. 37.
    Paakko E, Vainionpaa L, Phytinen J, Lanning M (1996) Minor changes on cranial MRI during treatment in children with acute lymphoblastic leukaemia. Neuroradiology 38:264–268PubMedGoogle Scholar
  38. 38.
    Caruso V, Iacoviello L, Di Castelnuovo A, Storti S, Mariani G, de Gaetano G, Donati MB (2006) Thrombotic complications in childhood acute lymphoblastic leukemia: a meta-analysis of 17 prospective studies comprising 1752 pediatric patients. Blood 108:2216–2222PubMedCrossRefGoogle Scholar
  39. 39.
    Morris EB, Laningham FH, Sandlund JT, Khan RB (2007) Posterior reversible encephalopathy syndrome in children with cancer. Pediatr Blood Cancer 48:152–159PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2007

Authors and Affiliations

  • Fred H. Laningham
    • 1
    • 5
  • Larry E. Kun
    • 3
    • 5
  • Wilburn E. Reddick
    • 2
  • Robert J. Ogg
    • 2
  • E. Brannon Morris
    • 4
  • Ching-Hon Pui
    • 4
    • 5
  1. 1.Division of Diagnostic Imaging (MS #210), Department of Radiological SciencesSt. Jude Children’s Research HospitalMemphisUSA
  2. 2.Division of Translational Imaging Research, Department of Radiological SciencesSt. Jude Children’s Research HospitalMemphisUSA
  3. 3.Division of Radiation Oncology, Department of Radiological SciencesSt. Jude Children’s Research HospitalMemphisUSA
  4. 4.Department of OncologySt. Jude Children’s Research HospitalMemphisUSA
  5. 5.University of Tennessee Health Sciences CenterMemphisUSA

Personalised recommendations